ArticleDiscover oncology2026

A PIK3CA and NF1 expression-based prognostic signature derived from Mendelian randomization identifies causal immune-regulatory determinants of glioblastoma outcomes.

Qinbiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.